Endocrine-based therapy is preferred over chemotherapy for hormone receptor [(HR, ER and/or progesterone receptor (PR)] -positive, HER2-negative ABC due to its effectiveness and lower toxicity [13]. The gene discussed is PGR; the disease is aneurysmal bone cyst.